HVM
MRNA icon

Harvest Volatility Management’s Moderna MRNA Stock Holding History

Harvest Volatility Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,722
Closed -$1.42M – 88
2023
Q2 		$1.42M Sell
11,722
-2,125
-15% -$283K 0.29% 60
2023
Q1 		$2.04M Sell
13,847
-2,277
-14% -$376K 0.41% 45
2022
Q4 		$2.9M Sell
16,124
-4,587
-22% -$750K 0.58% 36
2022
Q3 		$2.44M Sell
20,711
-1,156
-5% -$175K 0.42% 46
2022
Q2 		$3.12M Sell
21,867
-2,659
-11% -$380K 0.5% 42
2022
Q1 		$4.22M Buy
24,526
+24,501
+98,004% +$4.12M 0.48% 38
2021
Q4 		$6.28K Sell
25
-18,580
-100% -$5.43M ﹤0.01% 45
2021
Q3 		$7.16M Buy
18,605
+7,076
+61% +$2.61M 0.33% 26
2021
Q2 		$2.71M Buy
11,529
+2,848
+33% +$509K 0.22% 39
2021
Q1 		$1.14M Buy
8,681
+3,370
+63% +$488K 0.1% 56
2020
Q4 		$555K Buy
+5,311
New +$537K 0.06% 74

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Harvest Volatility Management's MRNA Position: Q3 2023 in Review

Harvest Volatility Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 11,722 shares — an estimated $1.42M sold.

Harvest Volatility Management first reported a position in MRNA in Q4 2020 and held it in 11 quarters. The position peaked at $7.16M in Q3 2021. 888 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Harvest Volatility Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 11,722 Moderna shares in Q3 2023, an estimated $1.42M.
  • Harvest Volatility Management first reported a position in Moderna in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's Moderna position peaked at $7.16M in Q3 2021.
  • 888 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.